SYD-101

DEL MAR, California, May 1, 2026 Sydnexis, Inc. announced it will present new Phase 3 STAR trial data for...

Del Mar, California, USA | March 23, 2026 Sydnexis, Inc. has announced new Phase 3 clinical data from its...